发明申请
US20090269305A1 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
失效
HEPATITIS C病毒复制的新型MACROCYCLIC抑制剂
- 专利标题: NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
- 专利标题(中): HEPATITIS C病毒复制的新型MACROCYCLIC抑制剂
-
申请号: US12423681申请日: 2009-04-14
-
公开(公告)号: US20090269305A1公开(公告)日: 2009-10-29
- 发明人: Scott D. Seiwert , Leonid Beigelman , Brad Buckman , Antitsa Dimitrova Stoycheva , Steven B. Porter , Williamson Ziegler Bradford , Vladimir Serebryany
- 申请人: Scott D. Seiwert , Leonid Beigelman , Brad Buckman , Antitsa Dimitrova Stoycheva , Steven B. Porter , Williamson Ziegler Bradford , Vladimir Serebryany
- 申请人地址: US CA Brisbane
- 专利权人: InterMune, Inc.
- 当前专利权人: InterMune, Inc.
- 当前专利权人地址: US CA Brisbane
- 主分类号: A61K38/21
- IPC分类号: A61K38/21 ; C07D245/04 ; A61K31/4709 ; C12N9/99 ; A61K31/7056 ; A61K31/4738 ; A61K31/407 ; A61K31/4725 ; A61K31/517 ; A61P31/14 ; A61P1/16
摘要:
The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
公开/授权文献
- US08048862B2 Macrocyclic inhibitors of hepatitis C virus replication 公开/授权日:2011-11-01
信息查询
IPC分类: